Lentiviral and Retroviral Vector Production
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Dana-Farber Cancer Institute
Other organizations : Candiolo Cancer Institute, Harvard University
Variable analysis
- Expression plasmid (1 μg)
- PsPAX2 (1 μg)
- VSV-G (200 ng)
- PMSCV (1 μg)
- PMD-MLV (1 μg)
- VSV-G (200 ng)
- MYC expression vector
- Lentivirus packaging
- Retrovirus packaging
- Generation of OPM2-TurboGFP-Luc cell line
- 293T packaging cells (6 × 10^5 cells/well)
- TransIT-LT1 Transfection reagent
- Cell culture conditions (5% CO2, 37°C)
- Puromycin dihydrochloride (1 μg/mL)
- Cell sorting (BD FACSAria III)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!